Hypoxia-responsive, organic-inorganic hybrid mesoporous silica nanoparticles for triggered drug release

Abstract Hypoxia is a manifestation of various diseases with an ischemic component, including cancer. Tumor hypoxia is a hallmark of cancer, creating an opportunity to exploit hypoxia to ensure delivery of anticancer drugs to cancer cells. Here, we describe the development of nanoparticles that specifically release drugs under hypoxic conditions. To this end, we prepared a hybrid mesoporous silica nanoparticle, modified to contain 4-(phenylazo)benzoic acid (4-PA, SNA) and β-cyclodextrin (β-CD, SNAC) on the external surface. 4-PA and β-CD act through host-guest interactions to serve as gatekeepers to block the pores of mesoporous sililica nanoparticles (SN), and subsequent selective cleavage of the azo group of 4-PA by intracellular nitroreductases under hypoxic conditions allows the release of entrapped drugs. Under normoxic conditions, doxorubicin (DOX)-loaded SNAC (DOX@SNAC) showed low cytotoxicity, reflecting inhibition of premature release of DOX from SNAC by 4-PA and β-CD. In contrast, under hypoxic conditions, DOX@SNAC showed significant cytotoxicity, similar to that of free DOX. Collectively, these results show that SNAC can function as effective drug-delivery systems in hypoxic conditions. Moreover, these SNACs, hypoxia-responsive hybrid mesoporous silica nanoparticles, could be effective not only in cancer, but also other diseases characterized by ischemic conditions.

• Publication year

  2020

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2020-04-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.jddst.2020.101543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesoporous nanocarriers with a stimulus-responsive cyclodextrin gatekeeper for targeting tumor hypoxia.

  2017cited by this paper
• A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.

  2017cited by this paper
• Light-Mediated Reversible Modulation of ROS Level in Living Cells by Using an Activity-Controllable Nanozyme.

  2017cited by this paper
• Intelligent Drug Delivery System Based on Mesoporous Silica Nanoparticles Coated with an Ultra-pH-Sensitive Gatekeeper and Poly(ethylene glycol).

  2016cited by this paper
• Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging.

  2015cited by this paper
• Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles

  2014cited by this paper
• Nanopreparations for organelle-specific delivery in cancer.

  2014cited by this paper
• Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.

  2014cited by this paper
• Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

  2013cited by this paper
• A pH gated, glucose-sensitive nanoparticle based on worm-like mesoporous silica for controlled insulin release.

  2013cited by this paper
• High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor.

  2013cited by this paper
• Mesoporous systems for poorly soluble drugs.

  2013cited by this paper
• The first latent green fluorophores for the detection of azoreductase activity in bacterial cultures.

  2013cited by this paper
• Functionalized mesoporous silica materials for controlled drug delivery.

  2012cited by this paper
• Functional mesoporous silica nanoparticles for photothermal-controlled drug delivery in vivo.

  2012cited by this paper
• Mesoporous silica nanoparticles in biomedical applications.

  2012cited by this paper
• Hypoxia-induced angiogenesis: good and evil.

  2011cited by this paper
• Towards biocompatible nanovalves based on mesoporous silica nanoparticles

  2011cited by this paper
• Mesoporous silica nanoparticles for intracellular controlled drug delivery.

  2010cited by this paper
• Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

  2008cited by this paper
• Hypoxia in cancer: significance and impact on clinical outcome

  2007cited by this paper
• Mesoporous materials for drug delivery.

  2007cited by this paper
• Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.

  2004cited by this paper
• Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

  2003cited by this paper
• Significance of blood vessel leakiness in cancer.

  2002cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Hypoxia-induced up-regulation of angiogenin in human malignant melanoma.

  1999cited by this paper
• DT-diaphorase and cancer chemotherapy.

  1992cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Exploring the Functional Diversity of Hypoxia-Responsive Polymers in Drug Delivery: A Comparative Analysis

  2026cites this paper
• Mesoporous silica nanoparticles with an azobenzene gatekeeper as hypoxia-responsive nanocarriers for targeted doxorubicin delivery.

  2025cites this paper
• Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles

  2024influential citation
• Mesoporous silica nanoparticles: Synthesis and multifaceted functionalization for controlled drug delivery

  2023cites this paper
• Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy

  2023cites this paper
• Flexible Curcumin-Loaded Zn-MOF Hydrogel for Long-Term Drug Release and Antibacterial Activities

  2023cites this paper
• Stimuli-Responsive Silica Silanol Conjugates: Strategic Nanoarchitectonics in Targeted Drug Delivery.

  2023cites this paper
• Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

  2022cites this paper
• Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

  2022cites this paper
• Surface modifications of gold nanoparticles: stabilization and recent applications in cancer therapy

  2022cites this paper
• Big family of nano- and microscale drug delivery systems ranging from inorganic materials to polymeric and stimuli-responsive carriers as well as drug-conjugates

  2021cites this paper
• Electrospun poly(lactic acid) (PLA)/poly(butylene adipate-co-terephthalate) (PBAT) nanofibers for the controlled release of cilostazol.

  2021cites this paper
• Research progress of response strategies based on tumor microenvironment in drug delivery systems

  2021cites this paper
• Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy

  2021cites this paper
• Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy

  2020cites this paper
• Emerging Strategies in Anticancer Combination Therapy Employing Silica‐Based Nanosystems

  2020cites this paper